Atlas Trials

Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"

Clinical trial NCT02221284 · COMPLETED

Trial details

NCT number
NCT02221284
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Type 2 Diabetes Mellitus
Start date
2014-06-30
Primary completion
2017-06-30
Enrollment
964

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.